checkmate 9la study: nivo ipi in nsclc
Published 4 years ago • 560 plays • Length 7:16Download video MP4
Download video MP3
Similar videos
-
2:28
perspectives on the checkmate 9la study
-
7:22
early updates from the checkmate73l study: nivo ccrt followed by nivo ipi in nsclc
-
5:43
checkmate 9la trial on nivolumab plus ipilimumab for nsclc
-
6:03
checkmate 9la: nivolumab, ipilimumab and chemotherapy for stage iv nsclc
-
3:30
checkmate 9la: tmb and immune checkpoint inhibitor efficacy
-
11:48
asco lung cancer roundtable - nsclc trial updates: checkmate 9la opdivo and yervoy with chemo vs
-
10:46
the checkmate 9la trial for stage iv/recurrent non-small cell lung cancer
-
1:22
dr. reck on safety data from the checkmate-9la trial in metastatic/recurrent nsclc
-
8:03
checkmate-9la: histology and frontline impact
-
4:05
checkmate 9la: first-line nivolumab ipilimumab 2 cycles chemotherapy vs 4 cycles chemo in an...
-
3:04
nsclc highlights at asco 2020
-
2:01
upcoming nsclc trials in 2022: checkmate 816 & keynote-091
-
10:46
the checkmate 9la trial for stage iv/recurrent non-small cell lung cancer
-
3:24
ipi/nivo in metastatic nsclc
-
2:33
checkmate 227: chemo-free nsclc treatment
-
11:44
checkmate 227 dual io therapy: nivo plus ipilimumab upfront for nsclc
-
10:12
nivolumab ipilimumab 2 cycles of platinum-doublet chemo vs 4 cycles chemo for stage iv nsclc
-
6:31
recent combination approval: checkmate-9la regimen
-
1:49
checkmate 901: hrqol findings of nivolumab and gemcitabine-cisplatin in uc